Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to NON-SMALL CELL LUNG CANCER (NSCLC)

ReachMD

CME: Practicing Precision in ALK and ROS1 Rearrangement Positive Non-Small Cell Lung Cancer (NSCLC): Testing, Targets, and Treatments

Oncology, Medical May 25th 2022

Cancer Therapy Advisor

Sintilimab Provides ‘Robust’ Survival Benefit in Advanced Non-Small Cell Lung Cancer (NSCLC)

Oncology, Medical May 25th 2022

Cancer Therapy Advisor

Neoadjuvant Nivolumab Plus Chemo Deemed New Standard Care for Resectable Non-Small Cell Lung Cancer (NSCLC)

Oncology, Medical May 25th 2022

OBR Oncology

Roche Cancer Immunotherapy Fails Another Trial, Casting Doubt On Emerging Drug Class

Oncology, Medical May 25th 2022

Journal of Clinical Oncology

COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination with Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non–Small-Cell Lung Cancer (NSCLC)

Oncology, Medical May 25th 2022

JAMA Network

Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients with Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)

Oncology, Medical March 22nd 2022